Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.

However, although there was a trend in both assays for mutation of the first bromodomain to produce a greater reduction in t1⁄2 than the second, which would be consistent with in vitro affinity studies [ 41 , 42 ], these differences failed to reach significance in ANOVA multiple comparisons testing.

also in 4,113 other papers